We have examined the physiological effects of antibodies from a highly specific myasthenic serum on acetylcholine receptors at developing rat endplates. The antibodies reduced the amplitude of miniature endplate potentials by 60% in 3-to 6-day-old animals but had no effect after day 14. Between days 7 and 12 the antibodies had an intermediate effect. This is the same period during which acetylcholine receptors with long channel open times (slow channels) disappear and receptors with short open times (fast channels) increase in number. Therefore, we examined the effect of the antibodies at endplates with a mixture of channel types more carefully. At all times tested, both noise analysis and analysis of miniature endplate currents showed that the antibodies reduced slow channel activity selectively. Single-channel recordings indicated that acetylcholine receptors that remained active after antibody treatment had normal gating properties. Thus, the antibodies appeared to silence slow channels selectively.Acetylcholine receptors (AcChoRs) change in several ways during formation of the skeletal neuromuscular junction (reviewed in ref. 1). At developing rat endplates, a striking functional change occurs postnatally: the apparent mean channel open time decreases by a factor of 3-5, and the single-channel conductance increases by about 50%. In rat soleus (20) and diaphragm (3) muscles, these changes in gating properties occur over a 2-week period beginning several days after birth. The transition at any individual endplate probably occurs within a few days (3, 4). During the transition, individual endplates contain a mixture of slow, embryonic-like channels and fast, adult-like channels.Several molecular properties of the AcChoR also change during muscle endplate development (reviewed in ref. 1). One of the molecular changes is detected by a class of antibodies (Abs) found in the serum of most patients with myasthenia gravis. These Abs recognize one or more determinants that are present on AcChoRs in the extrajunctional membrane of embryonic muscle but are not found on AcChoRs at adult endplates (5). Recently, a myasthenic serum that is highly specific for the embryonic type of AcChoR has been used to characterize AcChoRs at developing endplates (6). AcChoRs at endplates of newborn, but not adult, rats bind Abs in this serum. Endplate AcChoRs lose their reactivity to the Abs during the second and third postnatal weeks (7).The parallel in time course of the loss of immunoreactivity and the transition in channel properties suggests that Abs in this serum might bind specifically to AcChoRs with slow, embryonic-like channels. Because these Abs block AcChoR function (21), we have been able to test this hypothesis explicitly by examining the physiological effects of the myasthenic serum at developing endplates that contain a mixture of channel types. We report here that at all times tested, the serum appeared to block the slow channels selectively. This suggests that Abs in this serum detect a structural change in the...